세계의 OTC 수면 보조제 시장 : 예측(2025-2030년)

The OTC Sleep Aids Medication Market is expected to grow at a CAGR of 4.89%, reaching a market size of US$25.526 billion in 2030 from US$20.105 billion in 2025

Over-the-counter (OTC) sleep aid medications are drugs available without a prescription, designed to help with occasional sleeplessness or insomnia. These medications are typically recommended for treating infrequent sleepless nights. Commonly used OTC sleep aids include diphenhydramine, doxylamine, melatonin, and valerian. The market for these products features well-known brands such as Unison SleepTabs, ZzzQuil, Tylenol, Nytol, and Sominex.The OTC sleep aids medication market encompasses the production, distribution, and sale of nonprescription sleeping pills and natural supplements aimed at managing occasional sleeplessness, mild insomnia, temporary sleep disturbances, jet lag, and general restlessness. This market includes antihistamine-based medications, melatonin supplements, and herbal remedies like valerian root and chamomile.The growth of the OTC sleep aid medication market is driven by several factors. The rising prevalence of sleep disorders is largely attributed to modern lifestyle changes such as stress, anxiety, irregular work schedules, and excessive screen time. These factors have led to an increase in sleep disorders becoming common. As people become more aware of the importance of sleep health, there is a growing demand for sleeping pills or natural supplements to address their sleep issues. Additionally, the accessibility of OTC medications contributes to the continued growth of this market. Furthermore, there is a notable trend toward natural and herbal sleep aid medications that is expected to further boost market growth.

Drivers of the OTC Sleep Aids Medication Market:

• Rising Prevalence of Sleep Disorders: The modern lifestyle characterized by stress, anxiety, work pressure, and excessive screen time has led to a significant increase in individuals suffering from sleep disorders such as insomnia and parasomnia. According to data from the National Heart, Lung, and Blood Institute, approximately 50 to 70 million Americans experience sleep or wakefulness disorders. Additionally, the clinical guidelines for evaluating and managing chronic insomnia in adults estimate that around 33% to 50% of the adult population faces situational stress. These statistics indicate a growing trend in sleeplessness and suggest that the OTC sleep aid medication market will see substantial growth in the coming years.

Geographical Outlook of the OTC Sleep Aids Medication Market:

• Asia-Pacific Expected to Be the Fastest-Growing Region: The OTC sleep aids medication market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific. During the forecast period, Asia-Pacific is projected to be the fastest-growing region due to increasing cases of sleep disorders linked to modern lifestyles. Rising economic conditions are enabling consumers to afford these medications. Additionally, there is heightened awareness among individuals regarding sleep-related disorders and their treatment options.

In contrast, North America is expected to maintain a significant share of the market due to its advanced healthcare infrastructure. The high prevalence of sleep disorders and supportive infrastructure for medication access are key factors driving market growth in this region.In summary, the OTC sleep aid medication market is poised for robust growth driven by increasing awareness of sleep health issues, rising demand for effective solutions targeting insomnia and related disorders, advancements in product formulations, and significant geographical developments-particularly within Asia-Pacific-that enhance this expanding market landscape.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The OTC Sleep Aids Medication Market has been segmented as following:

By Type

• Antihistamine
• Melatonin Supplements
• Herbal Supplement
• Others

By Application

• Insomnia Treatment
• Anxiety Relief
• Others

By Distribution Channel

• Online
• Supermarkets/Hypermarkets
• Pharmacies and Drugstores
• Specialty Stores

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• South Korea
• Australia
• India
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. OTC SLEEP AIDS MEDICATION MARKET BY TYPE

• 5.1. Introduction
• 5.2. Antihistamine
• 5.3. Melatonin Supplements
• 5.4. Herbal Supplements
• 5.5. Others

6. OTC SLEEP AIDS MEDICATION MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Insomnia Treatment
• 6.3. Anxiety Relief
• 6.4. Others

7. OTC SLEEP AIDS MEDICATION MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Online
• 7.3. Supermarkets/Hypermarkets
• 7.4. Pharmacies and Drugstores
• 7.5. Specialty Stores

8. OTC SLEEP AIDS MEDICATION MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Type
  • 8.3.2. By Application
  • 8.3.3. By Distribution Channel
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Type
  • 8.4.2. By Application
  • 8.4.3. By Distribution Channel
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Type
  • 8.5.2. By Application
  • 8.5.3. By Distribution Channel
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Type
  • 8.6.2. By Application
  • 8.6.3. By Distribution Channel
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. South Korea
    • 8.6.4.4. Australia
    • 8.6.4.5. India
    • 8.6.4.6. Indonesia
    • 8.6.4.7. Thailand
    • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Pfizer Inc.
• 10.2. Sanofi S.A.
• 10.3. Johnson and Johnson
• 10.4. Reckitt Benckiser
• 10.5. Sundown Naturals
• 10.6. Proctor and Gamble
• 10.7. Bayer AG
• 10.8. Unilever